TLX Telix Pharmaceuticals Limited
$9.03▲ +0.44%
Healthcare
Other
After hours
$9.03▲ +0.00%
Oct 27, 4:01 PM ET
Volume 223.7K
Avg Volume (10D) 401.1K
Key Metrics & Fundamentals
Market Cap
$3.07B
P/E Ratio
90.3
Div Yield
0.00%
52W Range
6.28 - 13.11
% vs 50 MA
-19.56%
% vs 200 MA
-8.59%
RSI-14
31.4
MACD Histogram
-0.2000
Beta (1Y vs SPY)
0.95
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News

3 Australian Insider Backed Growth Stocks To Own In October 2026
Simply Wall St. · Oct 27, 2026 7:14 PM ET

Regis Healthcare And 2 Australian Insider Backed Growth Stocks
Simply Wall St. · Oct 26, 2026 4:11 PM ET

Our Pick Of The Best Australian Growth Stocks In October 2026
Simply Wall St. · Oct 25, 2026 9:06 AM ET
Telix Pharmaceuticals Q3 Revenue Rises 19%
MT Newswires · Oct 21, 2026 4:24 AM ET

Telix Reports Third Quarter 2026 Financial Performance
GlobeNewswire · Oct 20, 2026 6:10 PM ET

Telix Reports Third Quarter 2026 Financial Performance
PR Newswire · Oct 20, 2026 6:08 PM ET

3 Australian Growth Stocks With Revenue Growth Up To 38%
Simply Wall St. · Oct 20, 2026 12:11 PM ET

GE HealthCare Wins Approval for MINItrace Magni Cyclotron in Europe
Zacks · Oct 20, 2026 9:00 AM ET

3 Australian Growth Stocks To Own In October 2026
Simply Wall St. · Oct 19, 2026 10:13 AM ET
TLX, Ekalia Team Up to Boost US Production of Isotope for Cancer Therapies
MT Newswires · Oct 19, 2026 4:25 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.